cell.com
CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance
Immunotherapies only provide benefit for a subset of individuals with cancer, highlighting
the need for biomarkers of response. Using whole-genome CRISPR-Cas9 screens, Watterson
et al. map genetic dep...